PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells.
Although oxidant generation by NADPH oxidase is known to play an important role in signaling in endothelial cells, the basis of activation of NADPH oxidase is incompletely understood. The atypical isoform of protein kinase C, PKCzeta, has been implicated in the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced oxidant generation in endothelial cells; thus, in the present study, we have addressed the role of PKCzeta in regulating NADPH oxidase function. We showed by immunoblotting and confocal microscopy the presence of the major cytosolic NADPH oxidase subunits, p47(phox) and membrane-bound gp91(phox) in human pulmonary artery endothelial (HPAE) cells. TNF-alpha failed to activate oxidant generation in lung vascular endothelial cells derived from p47(phox-/-) and gp91(phox-/-) mice, indicating the requirement of NADPH oxidase in mediating the oxidant generation in endothelial cells. Stimulation of HPAE cells with TNF-alpha resulted in the phosphorylation of p47(phox) and its association with gp91(phox). Inhibition of PKCzeta by multiple pharmacological and genetic approaches prevented the TNF-alpha-induced phosphorylation of p47(phox), and its translocation to the membrane. PKCzeta was shown to colocalize with p47(phox), and inhibition of PKCzeta activation prevented the interaction of p47(phox) with gp91(phox) induced by TNF-alpha. Furthermore, inhibition of association of p47(phox) with gp91(phox) prevented the oxidant generation in endothelial cells. These data demonstrate a novel function of PKCzeta in signaling oxidant generation in endothelial cells by the activation of NADPH oxidase, which may be important in mediating endothelial activation responses.
Frey
Randall S
RS
Department of Pharmacology, University of Illinois College of Medicine, Chicago, IL 60612-7343, USA.
Rahman
Arshad
A
Kefer
John C
JC
Minshall
Richard D
RD
Malik
Asrar B
AB
D000818:Animals; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases / Q000378:metabolism*; D016877:Oxidants / Q000378:metabolism; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D011493:Protein Kinase C / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D000099221:Protein Kinase C zeta
D008562:Membrane Glycoproteins; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases; D016877:Oxidants; D010750:Phosphoproteins; D011493:Protein Kinase C; D014409:Tumor Necrosis Factor-alpha; D000099221:Protein Kinase C zeta; C056558:CYBB protein, human; C060505:neutrophil cytosolic factor 1